Expanded Access to ABBV-CLS-484
ConditionAdvanced Solid Tumor Cancer
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexNot listed
AgeNot listed
SponsorCalico Life Sciences LLC
About this trial
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- DRUG: ABBV-CLS-484
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov